These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 8102552
41. Selegiline (L-deprenyl) and L-dopa treatment of Parkinson's disease: a double-blind trial. Takahashi M, Yuasa R, Imai T, Tachibana H, Yorifuji S, Nakamura Y, Ogawa N. Intern Med; 1994 Sep; 33(9):517-24. PubMed ID: 8000101 [Abstract] [Full Text] [Related]
43. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. McGrath JJ, Soares KV. Cochrane Database Syst Rev; 2000 Sep; (2):CD000459. PubMed ID: 10796546 [Abstract] [Full Text] [Related]
44. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Chakos MH, Alvir JM, Woerner MG, Koreen A, Geisler S, Mayerhoff D, Sobel S, Kane JM, Borenstein M, Lieberman JA. Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009 [Abstract] [Full Text] [Related]
55. Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial. Diehl A, Reinhard I, Schmitt A, Mann K, Gattaz WF. Eur Psychiatry; 2009 Jan 15; 24(1):33-40. PubMed ID: 18774276 [Abstract] [Full Text] [Related]
56. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder. Correll CU, Josiassen RC, Liang GS, Burke J, O'Brien CF. Psychopharmacol Bull; 2017 Aug 01; 47(3):53-60. PubMed ID: 28839340 [Abstract] [Full Text] [Related]